The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels

E.T. te Beek; X. Chen; G.E. Jacobs; K.J. Nahon; M.L. de Kam; J. Lappalainen; A.J. Cross; J.M.A. van Gerven; J.L. Hay

doi:10.1002/cpdd.134

The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels

E.T. te Beek
, X. Chen
, G.E. Jacobs
, K.J. Nahon
, M.L. de Kam
, J. Lappalainen
, A.J. Cross
, J.M.A. van Gerven
, J.L. Hay

Research output: Contribution to journal › Article › Academic › peer-review

10 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	149-154
Journal	Clinical pharmacology in drug development
Volume	4
Issue number	2
DOIs	https://doi.org/10.1002/cpdd.134
Publication status	Published - 2015

Access to Document

10.1002/cpdd.134

The-effects-of-the-nonselective-benzodiazepine-lorazepam-and-the-alpha2alpha3-subunit-selective-gabaa-receptor-mo.pdfFinal published version, 171 KBLicence: Taverne

Cite this

te Beek, E. T., Chen, X., Jacobs, G. E., Nahon, K. J., de Kam, M. L., Lappalainen, J., Cross, A. J., van Gerven, J. M. A., & Hay, J. L. (2015). The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels. Clinical pharmacology in drug development, 4(2), 149-154. https://doi.org/10.1002/cpdd.134

@article{cc2f40d41c364b03ae8e5f8e2690329c,

title = "The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels",

author = "\{te Beek\}, E.T. and X. Chen and G.E. Jacobs and K.J. Nahon and \{de Kam\}, M.L. and J. Lappalainen and A.J. Cross and \{van Gerven\}, J.M.A. and J.L. Hay",

year = "2015",

doi = "10.1002/cpdd.134",

language = "Undefined/Unknown",

volume = "4",

pages = "149--154",

journal = "Clinical pharmacology in drug development",

issn = "2160-7648",

publisher = "Wiley Blackwell",

number = "2",

}

te Beek, ET, Chen, X, Jacobs, GE, Nahon, KJ, de Kam, ML, Lappalainen, J, Cross, AJ, van Gerven, JMA & Hay, JL 2015, 'The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels', Clinical pharmacology in drug development, vol. 4, no. 2, pp. 149-154. https://doi.org/10.1002/cpdd.134

The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels. / te Beek, E.T.; Chen, X.; Jacobs, G.E. et al.
In: Clinical pharmacology in drug development, Vol. 4, No. 2, 2015, p. 149-154.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Effects of the Nonselective Benzodiazepine Lorazepam and the alpha(2)/alpha(3) Subunit-Selective GABA(A) Receptor Modulators AZD7325 and AZD6280 on Plasma Prolactin Levels

AU - te Beek, E.T.

AU - Chen, X.

AU - Jacobs, G.E.

AU - Nahon, K.J.

AU - de Kam, M.L.

AU - Lappalainen, J.

AU - Cross, A.J.

AU - van Gerven, J.M.A.

AU - Hay, J.L.

PY - 2015

Y1 - 2015

U2 - 10.1002/cpdd.134

DO - 10.1002/cpdd.134

M3 - Article

C2 - 27128218

SN - 2160-7648

VL - 4

SP - 149

EP - 154

JO - Clinical pharmacology in drug development

JF - Clinical pharmacology in drug development

IS - 2

ER -